Abstract
Cytochrome P450 (P450) enzymes are involved in the oxidations of numerous steroids, eicosanoids, alkaloids, and other endogenous substrates. These enzymes are also the major ones involved in the oxidation of potential toxicants and carcinogens such as those encountered among pollutants, solvents, and pesticides, as well as many natural products. A proper understanding of the basic mechanisms by which the P450 enzymes oxidize such compounds is important in developing rational strategies for the evaluation of the risks of these compounds.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Aoyama, T., Yamano, S., Guzelian, P.S., Gelboin, H.V., and Gonzalez, F.J. 1990, 5 of 12 forms of vaccinia virus-expressed human hepatic cytochrome-P450 metabolically activate aflatoxin B1, Proc. Natl. Acad. Sci. USA. 87: 4790–4793.
Baertschi, S.W., Raney, K.D., Shimada, T., Harris, T.M., and Guengerich, F.P. 1989, Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1, and sterigmatocystin and activities of the epoxides in forming guanyl-N 7 adducts and inducing different genetic responses, Chem. Res. Toxicol.. 2: 114–122.
Baertschi, S.W., Raney, K.D., Stone, M.P., and Harris, T.M. 1988, Preparation of the 8,9-epoxide of the mycotoxin aflatoxin B1: The ultimate carcinogenic species, J. Am. Chem. Soc.. 110: 7929–7931.
Battista, J.R. and Marnett, L.J. 1985, Prostaglandin H syntha1se-dependent epoxidation of aflatoxin B1, Carcinogenesis. 6: 1227–1229.
Buening, M.K., Chang, R.L., Huang, M.R., Fortner, J.G., Wood, A.W., and Conney, A.H. 1981, Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids, Cancer Res. 41: 67–72.
Buening, M.K., Fortner, J.G., Kappas, A., and Conney, A.H. 1978, 7,8-Benzoflavone stimulates the metabolic activation of aflatoxin B1 to mutagens by human liver, Biochem. Biophys. Res. Commun. 82: 348–355.
Busby, W.F. and Wogan, G.N., 1984, Aflatoxins, in: Chemical Carcinogens (Searle, C.E., ed.) Amer. Chem. Soc, Washington, D.C., pp. 945–1136.
Eaton, D.L. and Gallagher, E.P. 1994, Mechanisms of aflatoxin carcinogenesis, Annu. Rev. Pharmacol. Toxicol. 34: 135–172.
Forrester, L.M., Neal, G.E., Judah, D.J., Glancey, M.J., and Wolf, C.R. 1990, Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver, Proc. Natl. Acad. Sci. USA. 87: 8306–8310.
Garner, R.C., Miller, E.C., and Miller, J.A. 1972, Liver microsomal metabolism of aflatoxin B1 to a reactive derivative toxic to Salmonella typhimurium TA 1530, Cancer Res.. 32: 2058–2066.
Gillam, E.M.J., Baba, T., Kim, B-R., Ohmori, S., and Guengerich, F.P. 1993, Expression of modified human cytochrome P450 3 A4 in Escherichia coli and purification and reconstitution of the enzyme, Arch. Biochem. Biophys.. 305: 123–131.
Gillam, E.M.J., Guo, Z., Ueng, Y-F., Yamazaki, H., Cock, I., Reilly, P.E.B., Hooper, W.D., and Guengerich, F.P., 1994, Expression of cytochrome P450 3A5 in Escherichia coli: Effects of 5’ modifications, purification, spectral characterization, reconstitution conditions, and catalytic activities, Arch. Biochem. Biophys., in press.
Guengerich, F.P. and Kim, D-H. 1991, Enzymatic oxidation of ethyl carbamate to vinyl carbamate and its role as an intermediate in the formation of 1,N 6-ethenoadenosine, Chem. Res. Toxicol.. 4: 413–421.
Guengerich, F.P. and Macdonald, T.L., 1993, Sequential electron transfer oxidation reactions catalyzed by cytochrome P-450 enzymes, in: Advances in Electron Transfer Chemistry, Vol. 3 (Mariano, P.S., ed.) JAI Press, Greenwich, CT, pp. 191–241.
Guengerich, F.P. and Macdonald, T.L. 1990, Mechanisms of cytochrome P-450 catalysis, FASEB J.. 4: 2453–2459.
Guengerich, F.P. and Shimada, T. 1991, Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes, Chem. Res. Toxicol. 4: 391–407.
Guengerich, F.P., 1995, Human cytochrome P450 enzymes, in: Cytochrome P450 (Ortiz de Montellano, P.R., ed.) Plenum Press, New York, in press.
Guengerich, F.P., Bell, L.C., and Okazaki, O., 1995, Interpretations of cytochrome P450 mechanisms from kinetic studies, Biochimie, in press.
Guengerich, F.P., Kim, B-R., Gillam, E.M.J. and Shimada, T., 1994, Mechanisms of enhancement and inhibition of cytochrome P450 catalytic activity, in: Proceedings, 8th Int. Conf. on Cytochrome P450: Biochemistry, Biophysics, and Molecular Biology (Lechner, M.C., ed.) John Libbey Eurotext, Chichester, U.K., pp. 97–101.
Guengerich, F.P. 1991, Reactions and significance of cytochrome P-450 enzymes, J. Biol. Chem.. 266: 10019–10022.
Guengerich, F.P. 1992, Metabolic activation of carcinogens, Pharmacol. Ther.. 54: 17–61.
Guillouzo, A., Beaune, P., Gascoin, M. N., Begue, J. M., Campion, J. P., Guengercih, F. P., and Guguen-Guillouzo, C. 1985, Maintenance of cytochrome P-450 in cultured adult human hepatocytes, Biochem. Pharmacol. 34: 2991–2995.
Guo, Z., Gillam, E.M.J., Ohmori, S., Tukey, R.H., and Guengerich, F.P. 1994, Expression of modified human cytochrome P450 1A1 in Escherichia colt Effects of 5’ substitution, stabilization, purification, spectral characterization, and catalytic properties, Arch. Biochem. Biophys.. 312: 436–446.
Iyer, R., Coles, B., Raney, K.D., Thier, R., Guengerich, F.P., and Harris, T.M. 1994, DNA adduction by the potent carcinogen aflatoxin B, mechanistic studies, J. Am. Chem. Soc.. 116: 1603–1609.
Iyer, R.S. and Harris, T.M. 1993, Preparation of aflatoxin B, 8,9-epoxide using m-chloroperbenzoic acid, Chem. Res. Toxicol.. 6: 313–316.
Meyer, D.J., Coles, B., Harris, J., Gilmore, K.S., Raney, K.D., Harris, T.M., Guengerich, F.P., Kensler, T.W. and Ketterer, B., 1993, Induction of rat liver GSH transferases by 1,2-dithiole-3-thione illustrates both anticarcinogenic and tumor-promoting properties, in: Antimutagenesis and Anticarcinogenesis Mechanisms III (Bonzetti, G., Hayatsu, H., DeFlora, S., Waters, M.D. and Shenkel, D.M., eds.) Plenum Press, New York, pp. 171–179.
Ortiz de Montellano, P.R., 1986, Oxygen activation and transfer, in: Cytochrome P-450 (Ortiz de Montellano, PR., ed.) Plenum Press, New York, pp. 217–271.
Pohl, L.R., Branchflower, R.V., Highet, R.J., Martin, J.L., Nunn, D.S., Monks, T.J., George, J.W., and Hinson, J.A. 1981, The formation of diglutathionyl dithiocarbonate as a metabolite of chloroform, bromotrichloromethane, and carbon tetrachloride, Drug Metab. Dispos.. 9: 334–339.
Raney, K.D., Coles, B., Guengerich, F.P., and Harris, T.M. 1992a, The endo 8,9-epoxide of aflatoxin B1: Anew metabolite, Chem. Res. Toxicol.. 5: 333–335.
Raney, K.D., Meyer, DJ., Ketterer, B., Harris, T.M., and Guengerich, F.P. 1992b, Glutathione conjugation of aflatoxin B1 exo and endo epoxides by rat and human glutathione S-transferases, Chem. Res. Toxicol.. 5: 470–478.
Raney, K.D., Shimada, T., Kim, D-H., Groopman, J.D., Harris, T.M., and Guengerich, F.P. 1992c, Oxidation of aflatoxins and sterigmatocystin by human liver microsomes: Significance of aflatoxin Q1 as a detoxication product of aflatoxin B1, Chem. Res. Toxicol.. 5: 202–210.
Sandhu, P., Guo, Z., Baba, T., Martin, M.V., Tukey, R.H., and Guengerich, F.P. 1994, Expression of modified human cytochrome P450 1A2 in Escherichia coli: Stabilization, purification, spectral characterization, and catalytic activities of the enzyme, Arch. Biochem. Biophys.. 309: 168–177.
Shimada, T. and Guengerich, F.P. 1989, Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver, Proc. Natl. Acad. Sci. USA. 86: 462–465.
Shimada, T., Iwasaki, M., Martin, M.V., and Guengerich, F.P. 1989, Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA1535/pSK1002, Cancer Res.. 49: 3218–3228.
Shimada, T., Nakamura, S., Imaoka, S., and Funae, Y. 1987, Genotoxic and mutagenic activation of aflatoxin B1 by constitutive forms of cytochrome P-450 in rat liver microsomes, Toxicol. Appl. Pharmacol. 91: 13–21.
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y, and Guengerich, F.P. 1994, Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians, J. Pharmacol. Exp. Ther.. 270: 414–423.
Ueng, Y-F., Shimada, T., Yamazaki, H., and Guengerich, F.P., 1994, Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes, Chem. Res. Toxicol., in press.
Wood, A.W., Chang, R.L., Levin, W., Thakker, D.R., Yagi, H., Sayer, J.M., Jerina, D.M., and Conney, A.H. 1984, Mutagenicity of the enantiomers of the diastereomeric bay-region benzo(c)phenanthrene 3,4-diol-l,2-epoxides in bacterial and mammalian cells, Cancer Res.. 44: 2320–2324.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Guengerich, F.P. et al. (1996). Activation of Toxic Chemicals by Cytochrome P450 Enzymes. In: Snyder, R., et al. Biological Reactive Intermediates V. Advances in Experimental Medicine and Biology, vol 387. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9480-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9480-9_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9482-3
Online ISBN: 978-1-4757-9480-9
eBook Packages: Springer Book Archive